Centre for Cancer Biomarkers CCBIO

CCBIO's 3rd symposium (2015)

Many of the world's top cancer researchers presented the latest in cancer research when the Centre for Cancer Biomarkers invited to the annual two-day symposium at Solstrand May 19-20 2015. This time, about 200 participants spent 2 days together with cancer research as main focus.

Group photo of CCBIO PIs and speakers at CCBIOs Annual Symposium 2015
Group photo of CCBIO PIs and speakers at CCBIOs Annual Symposium 2015
Ingvild Festervoll Melien

Main content

- As a Centre of Excellence it is important for us to be excellent in education as well as in research. The symposium at Solstrand facilitates that students and researchers can make new contacts and catch up on the latest research in their field. At the same time the setting itself gives you room to think out of the box, Lars A. Akslen says. Read more here.


The scientific programme was as follows (also see as pdf):


Day 1: Tuesday May 19, 2015
09:00-10:00 Registration and coffee
10:00-10:15 Lars A. Akslen (Director of CCBIO): Introduction to CCBIO Symposium 2015.

Chair: James Lorens
10:15-11:00 Jean Paul Thiery (Singapore): Epithelial-Mesenchymal Transition (EMT)-based Therapeutic Strategies in Cancer
11:00-11:45 Thomas Brabletz (Erlangen): Cellular plasticity in cancer: driving force and therapeutic target
11:45-12:15 Randolph Watnick (Boston): The role of Notch1 and p53 in modulating the cancer stem cell phenotype.


Chair: Roger Strand
14:15-14.45 John Cairns (London): Challenges in valuing the benefits of new cancer therapies
14:45-15:15 Ole Frithjof Norheim (Bergen): Valuing the benefits of new therapies: recommendations from the third national committee on priority setting in Norway
15:15-15:45 Roger Strand (Bergen): Sociotechnical Imaginaries of Cancer Biomarkers - a Preliminary Analysis

15:45-16:15 COFFEE

Chair: Rolf Reed
16:15-16:45 Thorarinn Gudjonsson (Reykjavik): Cellular processes during breast morpho- genesis and EMT: an approach from 3D culture
16:45-17:15 James Lorens (Bergen): Multipotent mammary stem cell activity requires Axl receptor tyrosine kinase
17:15-17:45 Karl-Henning Kalland (Bergen): Prostate cancer - new therapeutic approaches

19:00 DINNER

Day 2: Wednesday May 20, 2015

Chair: Arne Östman
09:00-09:45 David Tuveson (New York): Pancreatic Cancer Models and Medicine
09:45-10:15 Arne Östman (Stockholm): Cancer-associated fibroblasts and pericytes as sources of prognostic and predictive information
10:15-10:45 Per Øyvind Enger (Bergen): Brain tumor stroma interactions from a translational perspective

10:45-11:15 COFFEE

Chair: Helga Salvesen
11:15-12:00 Ravi Bhatia (Birmingham, Al): Targeting leukemia stem cells in myeloid malignancies
12:00-12:30 Bjørn Tore Gjertsen (Bergen): Biomarkers in individialized cancer trials – hype or future cancer care?


Chair: Karl-Henning Kalland
14:15-15.00 Klaus Pantel (Hamburg): Liquid biopsy: Implications for cancer therapy
15:00-15:30 Odd Helge Gilja (Bergen): Ultrasound sonoporation applied experimentally and in patients with pancreatic adenocarcinoma
15:30-16.00 Guttorm Haraldsen (Oslo): Interleukin-33 - an important factor in stromal inflammation
16:00-16:30 Nils Halberg (Bergen): A microRNA Regulon that Mediates Breast Cancer Metastasis
16:30-16:45 Lars A. Akslen (Bergen): Closing remarks